2012
DOI: 10.1016/j.ajhg.2012.06.019
|View full text |Cite
|
Sign up to set email alerts
|

Rare De Novo Germline Copy-Number Variation in Testicular Cancer

Abstract: Although heritable factors are an important determinant of risk of early-onset cancer, the majority of these malignancies appear to occur sporadically without identifiable risk factors. Germline de novo copy-number variations (CNVs) have been observed in sporadic neurocognitive and cardiovascular disorders. We explored this mechanism in 382 genomes of 116 early-onset cancer case-parent trios and unaffected siblings. Unique de novo germline CNVs were not observed in 107 breast or colon cancer trios or controls … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 22 publications
(24 citation statements)
references
References 15 publications
1
23
0
Order By: Relevance
“…We then determine the remaining population level observables such as female incidence and sibling recurrence rates. The results for 1 are represented in Figure 1. The other two cases yield similar representations and are not shown.…”
Section: Threshold Modelsmentioning
confidence: 99%
See 3 more Smart Citations
“…We then determine the remaining population level observables such as female incidence and sibling recurrence rates. The results for 1 are represented in Figure 1. The other two cases yield similar representations and are not shown.…”
Section: Threshold Modelsmentioning
confidence: 99%
“…The match to 1 is shown in Figure 2. Targeting the higher and lower incidence rates does little to perturb the higher moments and those plots are included in the Supplement.…”
Section: Penetrance Modelsmentioning
confidence: 99%
See 2 more Smart Citations
“…Analysis of CNVs on a genomic scale is useful for assessing cancer progression and identifying congenital genetic abnormalities (Hicks et al 2006;Sebat et al 2007;Marshall et al 2008;Xu et al 2008;Levy et al 2011;Stadler et al 2012;Warburton et al 2014; for review, see Malhotra and Sebat 2012;Weischenfeldt et al 2013). CNVs are typically identified by microarray hybridization (Iafrate et al 2004;Sebat et al 2004) but can also be detected by next-generation sequencing (NGS).…”
mentioning
confidence: 99%